Urinary incontinence differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 11: Line 11:
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Pathophysiology
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Pathophysiology
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |History Findings
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |History Findings
! colspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" + |Signs and symptoms
! colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" + |Signs and symptoms
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Management
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Management
|-
|-
Line 21: Line 21:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ability hold urge
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ability hold urge
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Nocturia
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Nocturia
!Post-void residual volume
|-
|-
|Urge incontinence (detrusor instability)
|Urge incontinence (detrusor instability)
Line 44: Line 45:
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>++</nowiki>
|<nowiki>++</nowiki>
|< 50 ml
|
|
* Pelvic floor excercises
* Pelvic floor excercises
Line 68: Line 70:
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|< 50 ml
|
|
* Pelvic floor excercises
* Pelvic floor excercises
Line 94: Line 97:
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|> 200 ml
|
|
* Alpha-adrenergic blockers:
* Alpha-adrenergic blockers:
Line 122: Line 126:
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|Variable
|
|
* Symptomatic management
* Symptomatic management
Line 143: Line 148:
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|< 50 ml
|
|
* Cause-dependent
* Cause-dependent

Revision as of 17:51, 4 May 2018

Urinary incontinence Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Urinary incontinence from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray Findings

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Urinary incontinence differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Urinary incontinence differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Urinary incontinence differential diagnosis

CDC on Urinary incontinence differential diagnosis

Urinary incontinence differential diagnosis in the news

Blogs on Urinary incontinence differential diagnosis

Directions to Hospitals Treating Urinary incontinence

Risk calculators and risk factors for Urinary incontinence differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]

Differential diagnosis

Type Of Incontinence Causes Prevalence Pathophysiology History Findings Signs and symptoms Management
Urgency Frequency

(> 8 times/day)

Dribbling of urine Amount of dribbling with each episode of incontinence Ability hold urge Nocturia Post-void residual volume
Urge incontinence (detrusor instability)
  • Stroke
  • Alzheimer's disease
  • Parkinson's disease
  • Benign prostatic hyperplasia (BPH)
  • 9% in women age 40-44 years
  • 31% in women older than 75 years
  • 42% in men older than 75 years
  • Detrusor overactivity
  • Increased parasympathetic drive to the bladder (S2-S4)
  • Variable amount of urine loss; ranging from small volumes to complete emptying of the bladder
+ + -
  • Small to large volume
- ++ < 50 ml
  • Pelvic floor excercises
  • Oxybutynin
  • Tolterodine
Stress incontinence
  • Genitourinary surgical procedures
  • Multiple childbirths
  • 25-45% in women > 30 years
  • Weakness of the uretheral sphincter
  • Weakness of the pelvic floor muscles
  • Patient recognizes which activities promote incontinence
  • Incontinence with cough, sneezing, straining
- - +
  • Small volume
+ +/- < 50 ml
  • Pelvic floor excercises
  • Alpha agonists
  • Topical estrogen cream
Overflow incontinence
  • Benign prostatic hyperplasia
  • Fecal impaction
  • 5% of patients with chronic incontinence
  • More common in males
  • Overdistension of the bladder
  • Impaired bladder contractility
  • Bladder outlet obstruction (BOO)
  • Poor bladder emptying
  • Post-void urine volume > 200-300 ml
- - +
  • Small volume
+ + > 200 ml
  • Alpha-adrenergic blockers:
    • Tamsulosin
    • Terazosin
  • Catheterization
  • Diversion
Mixed incontinence (urge and stress)
  • Stroke
  • Alzheimer's disease
  • Parkinson's disease
  • Benign prostatic hyperplasia (BPH)
  • Genitourinary surgical procedures
  • Multiple childbirths
-
  • Combined urge and stress incontinence
  • Patient able to determine the pre-dominant symptoms
+ +/- +
  • Variable volume
+/- +/- Variable
  • Symptomatic management
Functional incontinence
  • Altered mental status
-
  • Inability to reach the toilet to urinate
  • Environmental barriers
  • Physical barriers
  • Immobility
  • Lower urinary tract deficits
- - +
  • Variable volume
+ + < 50 ml
  • Cause-dependent

References

Template:WH Template:WS